NCT07883200 Clinical and Radiographic Evaluation of E-IodoCal in Primary Molar Pulpectomy
| NCT ID | NCT07883200 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Pulpectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-11-25 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-11-25 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled split-mouth clinical trial evaluates the clinical and radiographic performance of E-IodoCal paste compared to zinc oxide-eugenol (ZOE) as root canal filling materials in primary molar pulpectomies.
Eligibility Criteria
Inclusion Criteria: Clinical: - * Healthy cooperative children with an age range of 4 - 8 years. * Nonvital deep carious mandibular primary second molars with sufficient coronal structure and at least 2/3rd root structure intact. * Pulp exposure where bleeding couldn't be stopped following removal of the coronal pulp tissue * Previous history of irreversible pulpitis signs and symptoms as spontaneous pain, percussion sensitivity, fistulous tract related to the involved tooth, and pathologic tooth mobility (grade-I mobility) Radiographic: * Adequate alveolar bone support (coverage by the bone of minimum two- thirds of at least one root). * Presence of interradicular radiolucency (discontinuity of lamina dura and/or furcation involvement less than or equal to half of the shortest root). Exclusion Criteria: Clinical: * Non-restorable primary molars with severe mobility (greater than grade-I mobility). * Children with systemic illness (any medically compromising condition). * Primary molars beyond possible repair. Radiographic: * Extensive internal resorption. * Extensive external pathological root resorption. * Obliteration of the root canal. * Physiological root resorption of more than a third of its length.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07883200 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 8 Years, studying Pulpectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07883200 currently recruiting?
Yes, NCT07883200 is actively recruiting participants. Contact the research team at shaimaaeldesouky@dent.tanta.edu.eg for enrollment information.
Where is the NCT07883200 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07883200 clinical trial?
NCT07883200 is sponsored by Tanta University. The trial plans to enroll 30 participants.